T. Rowe Price Health Care ETF
TMEDETF · Nasdaq
$34.82
+$0.00 (+0.01%)
EOD Oct 29, 2026
Key facts
- Expense ratio
- 0.44%
- Dividend yield (TTM)
- 0.46%
- Distributions
- Irregular
- Fund net assets (Jun 2026)
- $23M
- Stocks held
- 96
- Other positions
- 1
- Turnover (last fiscal year)
- 64.2%
- 52-week range
- $27.60 to $36.72
Top 10 holdings
All holdings47.5% of assets in ten stocks, as of Jun 30, 2026
| Company | Weight | Quality |
|---|---|---|
| 16.71% | 73 | |
| 6.52% | 48 | |
| 4.44% | 48 | |
| 4.11% | 31 | |
| 2.96% | 23 | |
| 2.75% | 66 | |
| 2.61% | 44 | |
| 2.60% | 81 | |
| 2.43% | 83 | |
| 2.38% | 75 |
Sector allocation
Share of the fund's assets
- Healthcare79.5%
- Industrials13.1%
- Consumer Discretionary4.2%
- Consumer Staples1.2%
- Technology0.2%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
8% of the fund's stock weight sits in companies with a Quality score above 75, 50% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States92.5%
- Denmark1.6%
- Germany1.6%
- Cayman Islands1.1%
- Netherlands0.9%
- Switzerland0.5%
- Canada0.3%
- Jersey0.3%
And 3 more countries.
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyTMED pays irregular. Over the last twelve months it paid $0.16 per share, a 0.46% yield at today's price. The latest payment was $0.16, ex-dividend Dec 23, 2025.
TMED questions
What does TMED invest in?+
T. Rowe Price Health Care ETF is an exchange-traded fund. Its largest holdings are Eli Lilly and Company (16.71%), UnitedHealth Group Incorporated (6.52%), Gilead Sciences Inc. (4.44%).
What is TMED's expense ratio?+
0.44% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $44.00 a year.
How much does TMED pay in dividends?+
TMED paid $0.16 per share over the last twelve months, a 0.46% yield at the Oct 29, 2026 close of $34.82. It pays irregular.
How good are the companies TMED owns?+
Weighted by position size, the stocks in TMED average a Quality score of 50 out of 100. 8% of the fund's stock weight sits in companies scoring above 75, 50% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Jun 30, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to n/a. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.